Estimation of Losartan Potassium and Ramipril in Their Combined Dosage Form by Validated HPTLC Method
More details
Hide details
Maliba Pharmacy College, INDIA
Kunjan B. Bodiwala   

Maliba Pharmacy College, Bardoli-Mahuva Road, Surat, India
Online publication date: 2016-12-15
Publication date: 2016-12-15
Eurasian J Anal Chem 2017;12(3):167–177
A sensitive, specific and precise high performance thin layer chromatographic method for estimation of Losartan potassium (LOS) and Ramipril (RAM) has been developed and validated. The method employed TLC aluminium plates pre-coated with silica gel 60 F254 as the stationary phase. The solvent system consisted of toluene: methanol: ethyl acetate (6: 3: 2, v/v/v). This system was found to give compact and dense spots for LOS and RAM (Rf value 0.35 ± 0.02 and 0.57 ± 0.02, respectively). Densitometric analysis of drug was carried out in the absorbance mode at 210 nm. The method was validated with respect to linearity, specificity, precision, limit of detection, limit of quantification and recovery. The linear regression analysis data for the calibration plots showed a good linear relationship with R2 = 0.9943 and 0.9963 for LOS and RAM respectively, in the concentration range of 200-1000 ng/spot for both the drugs. The LOD and LOQ were found to be 26.03 ng/spot and 78.88 ng/spot, respectively for LOS, 14.37 ng/spot and 43.56 ng/spot, respectively for RAM. Recovery of LOS and RAM were achieved in the range of 100.42-101.44 % and 100.80-102.41 %, respectively by developed method. Statistical analysis proves that the method is repeatable and specific for the estimation of LOS and RAM. Developed method was successfully applied for estimation of LOS and RAM in their combined dosage form.
Joel, G. H., Lee, E. L. (2001). Goodman & Gilman’s The Pharmacological basis of therapeutics, 10th International Edition. New York: McGraw Hill Publisher, pp. 829, 859-60.
Rang, H. P., Dale, M. M., Ritter, J. N., & Moore, P. K. (2003). Pharmacology, 5th Edition, Churchill Livingstone. Elsevier Science Ltd., pp. 307.
Tripathi, K. D. (2003). Essential of Medical Pharmacology, 5th Edition. New Delhi: Jaypee Brothers Medical, pp. 48-52.
The Indian Pharmacopoeia Commission, Government of India. (2010). Indian Pharmacopoeia, 6th Edition, volume 2. Ghaziabad: Ministry of Health and Family Welfare, pp. 806-809, 1076-1078, 1607-1609.
The Department of Health. (2010). British Pharmacopoeia, volume 2. Great Britain: Medicines and Healthcare Products Regulatory Agency (MHRA), pp. 1295-1297.
The USP Convention. (2009). The United States Pharmacopoeia-32 National Formulary-27, volume 2, Asian edition. Washington DC, pp. 1739-1740, 3474, 2499-2500.
Shah, S. A., Rathod, I. S., Suhagia, B. N., Savale, S. S., & Patel, J. B. (2001). Simultaneous Determination of Losartan and Hydrochlorothiazide in Combined Dosage Forms by First-Derivative Spectroscopy and High-Performance Thin-Layer Chromatography. Journal of AOAC International 84(6), 1715-1723.
Shah, S. A., Vyas, R. B., Vyas, B. A., Maniyar, N. R., Chauhan, R. S., & Shah, D. R. (2010). A method for content uniformity determination of atenolol and losartan potassium in combined tablet dosage form. Indian Journal of Pharmaceutical Science, 72(6), 792-794.
Hassan, U. L., Syed, S. Z., Syeda, F. A., Muhmad, T. A., & Tariq, I. (2013). Development and validation of analytical method for Losartan-copper complex using UV-vis spectrophotometry. Journal of Pharmaceutical Research, 12(3), 407-411.
Giuseppe, C., Giancarlo, P., Pietro, M., & Quaglia, M. (2000). Simultaneous determination of Losartan and Hydrochlorothiazide in tablets by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 23(1), 185-189.
Kathiresan, K., Gothandaraman, S., Kumar, M., Manickam, M., & Manavalan, R. (2008). Analytical method development and validation of Losartan potassium tablet by RP-HPLC. Rasayan Journal of Chemistry, 1(3), 521-525.
Dubey, R., Bhusari, V. K., & Dhaneshwar, S. R. (2011). Validated HPTLC method for simultaneous estimation of Losartan potassium and Metolazone in bulk drug and formulation. Der Pharmacia Lettre, 3(2), 334-342.
Hogan, B. L., Williams, M., Idiculla, A., Veysoglu, T., & Parente, E. (2000). Development and validation of a liquid chromatographic method for the determination of the related substances of Ramipril in Altace capsules. Journal of Pharmaceutical and Biomedical Analysis, 23, 637–651.
Belal, F., Al-Zaagi, I. A., Gadkariem, E. A., & Abounassif, M. A. (2001). A stability-indicating LC method for the simultaneous determination of Ramipril and hydrochlorothiazide in dosage forms. Journal of Pharmaceutical and Biomedical Analysis, 24, 335–342.
Gaikwad, A. V., Rajurkar, V. G., Shivakumar, T., Dama, G. Y., & Tare, H. L. (2011). Simultaneous Estimation of Ramipril & valsartan in Tablets by HPTLC. Indo-Global Journal of Pharmaceutical Sciences, 1(1), 99-112.
Lakshmi, K. S., Subramanian, L. S., & Pal, K. (2010). Stability indicating HPTLC method for simultaneous determination of Telmisartan and Ramipril in tablets. International Journal of Pharmacy and Pharmaceutical Sciences, 2(4), 127-129.
Gupta, V. K., Jain, R., Lukram, O. K., Agarwal, S., & Dwivedic, A. (2011). Simultaneous determination of Ramipril, Ramiprilat and Telmisartan in human plasma using liquid chromatography tandem mass spectrometry. Talanta, 83, 709– 716.